Blood biomarkers are commonly used in many cancers to help diagnose disease or predict survival. However, these biomarkers are often dichotomised to facilitate easy analysis and interpretation. This categorisation removes a vast amount of information, particularly either side of the enforced boundaries, which otherwise could give improved insights into the prognosis of individuals. This research focuses on using blood biomarkers measured at diagnosis, pre-treatment and post-treatment, in continuous form, to develop prognostic models in prostate (PCa) and oesophageal (OAC) cancers.
| Date of Award | Dec 2019 |
|---|
| Original language | English |
|---|
| Awarding Institution | - Queen's University Belfast
|
|---|
| Supervisor | Jaine Blayney (Supervisor) & Richard Kennedy (Supervisor) |
|---|
Temporal analysis of clinico-pathological variables and biomarkers in cancer
Halliday, S. (Author). Dec 2019
Student thesis: Doctoral Thesis › Doctor of Philosophy